Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
NPJ Precision Oncology
|
July 15, 2023
Actionability classification of variants of unknown significance correlates with functional effect
Amber Johnson, Patrick Kwok-Shing Ng, Michael Kahle, et al.
Oncotarget
|
May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Genevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
Nature Reviews. Clinical Oncology
|
January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Amber Johnson, Yifei Shen, Xiaofeng Zheng, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
International Journal of Cancer
|
August 19, 2024
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies
Sujay Kalathoor, Sanam Ghazi, Beryl Otieno, et al.
Clinical Chemistry
|
January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumors
Ken Chen, Funda Meric-Bernstam, Hao Zhao, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
NPJ Precision Oncology
|
July 15, 2023
Actionability classification of variants of unknown significance correlates with functional effect
Amber Johnson, Patrick Kwok-Shing Ng, Michael Kahle, et al.
Oncotarget
|
May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Genevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
Nature Reviews. Clinical Oncology
|
January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Amber Johnson, Yifei Shen, Xiaofeng Zheng, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
NPJ Precision Oncology
|
October 27, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
Henry Hiep Vo, Siqing Fu, David S Hong, et al.
International Journal of Cancer
|
August 19, 2024
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies
Sujay Kalathoor, Sanam Ghazi, Beryl Otieno, et al.
Clinical Chemistry
|
January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumors
Ken Chen, Funda Meric-Bernstam, Hao Zhao, et al.
Page
of 8